Flu Vaccine Demand Forecast: Flat Or Up Slightly Compared With Last Year
This article was originally published in The Pink Sheet Daily
Executive Summary
The five providers of the six approved seasonal influenza vaccines appear to be preparing for a similar season with similar sales in 2011-12 as they had last year.
You may also be interested in...
Flu Vaccine Production Down Slightly This Season; Strains Get Overhaul
FDA encourages people to get vaccinations since two of the three virus strains in this season’s flu vaccines differ from last season’s; several manufacturers plan to distribute slightly fewer doses in 2012-2013 than in the prior year.
Abbott's Kaletra Needs Stronger Warnings To Discourage Off-Label Use In Neonates, FDA Says
Abbott's combination protease inhibitor causes serious toxicity in newborns, the agency will tell its Pediatric Advisory Committee.
Abbott's Kaletra Needs Stronger Warnings To Discourage Off-Label Use In Neonates, FDA Says
Abbott's combination protease inhibitor causes serious toxicity in newborns, the agency will tell its Pediatric Advisory Committee.